Trial intelligence / Profile preview

Vonoprazan versus pantoprazole for stress ulcer prophylaxis in ICU patients

IRCT20260226068954N1Phase 3Completed

Sponsor
Semnan University of Medical Sciences
Start
May 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial in stress ulcer comparing Vonoprazan with Pantoprazole (2 arms). Primary endpoint: Mean gastric fluid pH in the first 72 hours of intervention. Started May 2026; status: completed.

02

Drugs

vonoprazanpantoprazole
03

Conditions

stress ulcer

Beyond the preview

Go deeper on IRCT20260226068954N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20260226068954N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call